Skip to main content
Premium Trial:

Request an Annual Quote

Biocept Regains Nasdaq Compliance

NEW YORK (GenomeWeb) – Biocept said this morning that it received notification yesterday from the Nasdaq that it has regained compliance with the exchange's minimum bid listing requirement.

Nasdaq notified the company last November that it had failed to maintain the required $1 per share minimum bid price, and faced delisting if it did not regain compliance within a 180-day grace period.

To regain compliance, the company successfully maintained the minimum closing bid price for at least 10 consecutive business days.

In Wednesday morning trading, shares of Biocept were down about 1 percent to $1.67.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.